SCHEMBL9769919

SCHEMBL9769919

CCOC(=O)CC(O)CC(O)/C=C/C(=C(c1ccc(F)cc1)c1ccc(F)cc1)n1nnnc1-c1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 3/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9769922 1.00 HMGCR (0.61) HMGCR
SCHEMBL9769923 0.89 HMGCR (0.77) HMGCR
SCHEMBL9769926 0.89 HMGCR (0.77) HMGCR
SCHEMBL9769858 0.88 HMGCR (0.51) HMGCR
SCHEMBL9769851 0.88 HMGCR (0.51) HMGCR
SCHEMBL9769883 0.87 HMGCR (0.77) HMGCR
SCHEMBL9769879 0.87 HMGCR (0.77) HMGCR
SCHEMBL10437579 0.81 HMGCR (0.53) HMGCR
SCHEMBL10437581 0.81 HMGCR (0.53) HMGCR
SCHEMBL9769786 0.80 HMGCR (0.74) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5070206-A INHIBITORS OF 3-HYDROXY-3-METHYLGLUTARYL COENZYME A REDUCTASE; ANTICHOLESTEROL, ANTILIPEMIC BRISTOL-MYERS COMPANY (US) 1991-12-03 US disclosed
US-5010205-A Antihypercholesterolemic tetrazol-1-yl intermediates BRISTOL-MYERS COMPANY (US) 1991-04-23 US disclosed
EP-0355820-A1 Antihypercholesterolemic tetrazol-1-yl compounds Bristol-Myers Squibb Company (US) 1990-02-28 EP disclosed
US-4870187-A ANTILIPEMIC, ATHEROSCLEROSIS BRISTOL-MYERS COMPANY (US) 1989-09-26 US disclosed